Your browser doesn't support javascript.
loading
SSTR2A is a diagnostic marker of trichogerminoma.
Legrand, Mélanie; Pissaloux, Daniel; Tirode, Franck; Tallet, Anne; Collin, Christine; Chantreau, Paul-Louis; Berthon, Patricia; Jullie, Marie-Laure; Sohier, Pierre; Calonje, Eduardo; Luzar, Bostjan; Moulonguet, Isabelle; Goto, Keisuke; Cokelaere, Kristof; Lamant, Laurence; Balme, Brigitte; Deschamps, Lydia; Macagno, Nicolas; Cribier, Bernard; Battistella, Maxime; de la Fouchardière, Arnaud; Kervarrec, Thibault.
Afiliação
  • Legrand M; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Pissaloux D; Department of Biopathology, Center Léon Bérard, Lyon, France.
  • Tirode F; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Tallet A; Department of Biopathology, Center Léon Bérard, Lyon, France.
  • Collin C; Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Equipe Labellisée Ligue contre le Cancer, Lyon, France.
  • Chantreau PL; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Berthon P; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Jullie ML; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
  • Sohier P; "Biologie des infections à polyomavirus" team, UMR INRA ISP 1282, Université de Tours, Tours, France.
  • Calonje E; French Network of Rare Skin Cancers, CARADERM, France.
  • Luzar B; Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France, CARADERM network.
  • Moulonguet I; French Network of Rare Skin Cancers, CARADERM, France.
  • Goto K; Department of Pathology, Hôpital Cochin, AP-HP, AP-HP.Centre - Faculté de Médecine, University Paris Cité, Paris, France.
  • Cokelaere K; Department of Dermatopathology, St John's Institute of Dermatology, St Thomas's Hospital, London, UK.
  • Lamant L; Institute of Pathology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia.
  • Balme B; Department of Pathology, APHP Hôpital Saint Louis, Université Paris Cité, Paris, France.
  • Deschamps L; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
  • Macagno N; Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Japan.
  • Cribier B; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
  • Battistella M; Department of Dermatology, Hyogo Cancer Center, Akashi, Japan.
  • de la Fouchardière A; Department of Pathology, Jan Yperman Hospital, Belgium.
  • Kervarrec T; Department of Pathology, CHU Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, Université Toulouse III Paul Sabatier, Toulouse, France.
J Eur Acad Dermatol Venereol ; 37(11): e1344-e1347, 2023 11.
Article em En | MEDLINE | ID: mdl-37421254
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina / Neoplasias de Anexos e de Apêndices Cutâneos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina / Neoplasias de Anexos e de Apêndices Cutâneos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article